A study involving STZ diabetes‐induced rats showed the ability of calycosin to hinder the development of DKD via the modulation of the NF‐κB/p65/NLRP3/TXNIP inflammasome cascade (Yosri et al. 2022). This evidence concerns the gene NLRP3 and diabetic kidney disease.